Mechanisms of proliferation-independent mutation

This project aims to uncover the mechanisms behind "clock" mutations that accumulate with age in non-dividing cells, using innovative single-cell sequencing to advance cancer research and aging insights.

Subsidie
€ 1.500.000
2022

Projectdetails

Introduction

DNA damage contributes to the ageing of tissues and causes mutations that drive cancer. However, the molecular mechanisms underlying many mutational processes are not understood, and neither is how much they contribute to disease. With a powerful new technology, I propose to close these major gaps for common "clock" mutations of unknown origin.

Background

The recent genome sequencing revolution has revealed unexpected diversity in mutational patterns. One pattern in particular is intriguing as it behaves as a molecular "clock": the number of mutations increases over time and correlates with age.

Although the textbook view of mutagenesis is that cell division is required to convert DNA damage into point mutations, surprisingly, non-dividing cells like neurons also accumulate "clock" mutations as a function of time. This indicates that "clock" mutations arise without genome replication.

Research Questions

Understanding how cells mutate independently of proliferation—and thus challenging the current paradigm of mutagenesis—is a fundamental question that has been hindered because assays to measure mutation require cell division.

Excitingly, I have overcome this major obstacle by establishing a powerful strategy to sensitively detect mutations in single cells, genome-wide. My group will combine this approach with targeted genetic manipulations in cells and mice to answer two central questions:

  1. How do cells mutate independently of proliferation?
  2. What drives these mutations in tissues?

Methodology

My novel insights into endogenous DNA damage from mouse genetics and genomics, combined with the innovative sequencing strategy that I have established, uniquely position me to answer these long-standing questions.

Impact

Together, the work proposed here will reveal the molecular mechanism(s) underlying the most common mutational process in humans: "clock" mutation. The methods, data, and insights from these groundbreaking studies will directly impact cancer research and uncover novel sources of DNA damage during aging.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-5-2022
Einddatum30-4-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAWpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Mechanisms of cellular response to errors in mitosis: a new, non-genetic approach to an old question

This project aims to investigate how mitotic errors and nuclear abnormalities influence cellular homeostasis and tumorigenesis through non-genetic mechanisms, utilizing advanced genomic and imaging techniques.

€ 1.498.111
ERC Starting...

Mutation rate determinants across cellular and evolutionary scales

This project investigates the mechanisms of mutation accumulation in germline and somatic cells across species to understand their origins and evolutionary implications for aging and disease.

€ 1.489.760
ERC Starting...

The molecular nexus coupling Cell Metabolism to Cell cycle and Genome Surveillance

This project aims to explore how reactive oxygen species (ROS) influence DNA replication and cell cycle dynamics during early development and cancer, using advanced cellular models and innovative analytical tools.

€ 1.499.329
ERC Synergy ...

Mutations in healthy tissues: a double-edged sword for tissues homeostasis

This project investigates how somatic mutations enhance the fitness of stem/progenitor cells to maintain tissue integrity and regenerative potential, linking ageing, mutations, and disease risk.

€ 9.808.142
ERC Starting...

Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageing

This project aims to identify and validate rare genetic variants linked to longevity using CRISPR/Cas9 and high-throughput screening to promote healthy aging and extend lifespan.

€ 1.500.000